718 AMG 509, a STEAP1 X CD3 Bispecific XmAb® 2+1 Immune Therapy, Exhibits Avidity-Driven Binding and Preferential Killing of High STEAP1-expressing Prostate and Ewing Sarcoma Cancer Cells
Regular and Young Investigator Award Abstracts(2020)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要